Please login to the form below

Not currently logged in
Email:
Password:

PR and Med Ed news in brief

Our weekly round up of healthcare PR stories

J&J linked with Olympic sponsorship deal

Speculation is mounting that Johnson & Johnson is set to become a top-tier sponsor of the Olympic Games. The US pharma company is expected to sign a £100m deal with the International Olympic Committee after the completion of the 2006 Winter Games in Turin next February. The deal would allow J&J to use the famous Olympic Rings trademark across all its products and have an exclusive presence at future Games up until at least the London Games in 2012.

Galliard wins GSK Avodart contract

Galliard Healthcare Communications has won the global PR contract for GlaxoSmithKline's (GSK) benign prostatic hyperplasia treatment Avodart. The London-based agency beat off competition from Edelman and Ketchum to replace Fleishman-Hillard, which declined to repitch for the account citing a conflict of interest. Galliard managing director Marika Freris will lead a four-strong team on the account, reporting to GSK's global scientific communications strategy team. GSK is currently investigating Avodart's use in the prevention of prostate cancer, a potentially lucrative market if it succeeds in clinical trials.

2nd September 2008

Share

] [PR and Med Ed news in brief, Our weekly round up of healthcare PR stories, News Article, , ,] -->

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics